search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
GUT HEAL ▶▶▶TH


Impacts microbiota on animal health


Changes in the intestinal micro- biota result in functional, immunological, and nutritional consequences for the host.


Intestinal microbiota are of fundamental importance for host health, because they help in maintaining gut homeostasis. So it is important to better understand the link with microbiota and animal health.


BY JAN S. SUCHODOLSKI, TEXAS A&M UNIVERSITY, USA T 24


he intestinal microbiota is the collection of microor- ganisms (bacteria, fungi, archaea, protozoa, and virus- es) within the gastrointestinal (GI) tract. Intestinal mi- crobiota are of fundamental importance for host health, because they help in maintaining gut homeostasis by competing with transient enteropathogens, and by producing immunomodulatory metabolites such as short-chain fatty ac- ids, secondary bile acids, and idol derivatives. Various studies across animal species have reported changes in microbial com- munities in acute and chronic gastrointestinal diseases. While many such studies have been performed in rodent models for human disease, in human patients, and recently in companion animals, relatively little is known about such changes in swine and poultry. Most commonly observed changes are decreases in the bacterial phyla Firmicutes (i.e., Lachnospiraceae, Rumino- coccaceae, Faecalibacterium) and Bacteroidetes, with concurrent increases in Proteobacteria (e.g., E. coli).


Use of metabolomics Changes in the intestinal microbiota result in functional, im- munological, and nutritional consequences for the host. It is important to better understand the functional consequences


▶ ALL ABOUT FEED | Volume 25, No. 10, 2017


of microbial dysbiosis. Recent emerging research in the field of metabolomics using various mass spectrometry platforms combined with metagenomic analysis of intestinal microbiota allows to measure simultaneously several hundred to thou- sands biochemical molecules derived by the host as well as bacteria. This approach allows identifying which molecular pathways are regulated by intestinal microbiota and how these pathways are affected by antibiotic use, nutrition, and intestinal disease. This exiting new approach may allow identi- fying which bacterial taxa are most important functional key species within the microbiota and may serve as novel probiot- ic candidates. Furthermore, identification of immunomodula- tory key metabolites may allow to directly administering these to animals as postbiotics. For example, changes in bile acid metabolism, short-chain fatty acid concentrations, and trypto- phan pathways have recently been reported in various animal species using metabolomic analyses. Especially changes in bile acid metabolism due to intestinal bacteria are of potential interest to the field of production animals, as intestinal bile acids in humans are now considered important signaling mol- ecules that regulate nutrient uptake, energy homeostasis, reg- ulate insulin and glucose levels, and provide anti-inflam- matory signals. Furthermore, physiological concentrations of secondary bile acids inhibit growth of enteropathogens (i.e., C. difficile) in the GI tract.


More studies are needed Clearly, the intestinal microbiota and its metabolites are emerging as an important target for modulation. More studies are needed to describe the intestinal microbiota changes in response to various diets, and across production platforms. The impact of diets and antibiotics on the intestinal microbio- ta, especially at low-dose growth promoting levels needs to be described in more details to better understand the mecha- nisms of food-conversion and potentially to develop better alternatives to antibiotics.


Jan Sucholdoski presented this information at the Antibiotic re- duction event in October (Rome, Italy), organised by Phileo. Near- ly 300 participants from 45 countries attended the event, which focused on the central theme of reducing antibiotic use and em- bracing the opportunities presented by a global market that is evolving rapidly on this topical issue.


PHOTO: SHUTTERSTOCK


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50